[11C]QC-33

N/A

Report date: 2025/11/24 11:49:40

Base Information

Drug Name[11C]QC-33

Drug Alias Name[11C]QC-33

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Radionuclide Drug ConjugatesRadiation-emitting products > Nuclides > Carbon > 11C +[5]

Mechanisms of ActionHeme oxygenase 1 inhibitors

TargetsHeme oxygenase 1

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesHarvard Medical School

China Registration ClassN/A

Develop Information

Active CompaniesHarvard Medical School

Inactive CompaniesN/A

Active IndicationsAlzheimer Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A